Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Invest Surg ; 30(1): 33-40, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27715338

RESUMO

AIM OF THE STUDY: To investigate the pulmonary oxidative stress and possible protective effect of N-Acetylcysteine (NAC) and Desferoxamine (DFX)in a porcine model subjected to hemorrhagic shock. MATERIALS AND METHODS: Twenty-one pigs were randomly allocated to Group-A (sham, n = 5), Group-B (fluid resuscitation, n = 8) and Group-C (fluid, NAC and DFX resuscitation, n = 8). Groups B and C were subjected to a 40-min shock period induced by liver trauma, followed by a 60-min resuscitation period. During shock, the mean arterial pressure (MAP) was maintained at 30-40 mmHg. Resuscitation consisted of crystalloids (35 mL/kg) and colloids (18 mL/kg) targeting to MAP normalization (baseline values ± 10%). In addition, Group-C received pretreatment with NAC 200 mg/kg plus DFX 2 g as intravenous infusions. Thiobarbituric Acid Reactive Substances (TBARS), protein carbonyls and glutathione peroxidase (GPx) activity were determined in lung tissue homogenates. Also, histological examination of pulmonary tissue specimens was performed. RESULTS: TBARS were higher in Group-B than in Group-A or Group-C: 2.90 ± 0.47, 0.57 ± 0.10, 1.78 ± 0.47 pmol/µg protein, respectively (p < 0.05). Protein carbonyls content was higher in Group-B than in Group-A or Group-C: 3.22 ± 0.68, 0.89 ± 0.30, 1.95 ± 0.54 nmol/mg protein, respectively (p > 0.05). GPx activity did not differ significantly between the three groups (p > 0.05). Lung histology was improved in Group-C versus Group-B, with less alveolar collapse, interstitial edema and inflammation. CONCLUSION: NAC plus DFX prevented the increase of pulmonary oxidative stress markers and protein damage after resuscitated hemorrhagic shock and had beneficial effect on lung histology. NAC/DFX combination may be used in the multimodal treatment of hemorrhagic shock, since it may significantly prevent free radical injury in the lung.


Assuntos
Acetilcisteína/uso terapêutico , Desferroxamina/uso terapêutico , Sequestradores de Radicais Livres/uso terapêutico , Pulmão/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Choque Hemorrágico/tratamento farmacológico , Sideróforos/uso terapêutico , Acetilcisteína/administração & dosagem , Animais , Biomarcadores/análise , Coloides , Soluções Cristaloides , Desferroxamina/administração & dosagem , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Hidratação/métodos , Glutationa Peroxidase/análise , Humanos , Infusões Intravenosas , Soluções Isotônicas/administração & dosagem , Pulmão/enzimologia , Pulmão/patologia , Masculino , Carbonilação Proteica/efeitos dos fármacos , Distribuição Aleatória , Soluções para Reidratação/administração & dosagem , Choque Hemorrágico/complicações , Suínos , Substâncias Reativas com Ácido Tiobarbitúrico/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA